| Application number | Title of the application | Filing Date | Status |
|---|
| 09/629021 | Treatment of tumors with genetically engineered herpes virus | Jul 30, 2000 | Abandoned |
Array
(
[id] => 1560852
[patent_doc_number] => 06361972
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-26
[patent_title] => 'Compositions and methods for non-targeted activation of endogenous genes'
[patent_app_type] => B1
[patent_app_number] => 09/481375
[patent_app_country] => US
[patent_app_date] => 2000-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 62
[patent_figures_cnt] => 101
[patent_no_of_words] => 62457
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/361/06361972.pdf
[firstpage_image] =>[orig_patent_app_number] => 09481375
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/481375 | Compositions and methods for non-targeted activation of endogenous genes | Jan 9, 2000 | Issued |
Array
(
[id] => 1531857
[patent_doc_number] => 06410266
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-25
[patent_title] => 'Compositions and methods for non-targeted activation of endogenous genes'
[patent_app_type] => B1
[patent_app_number] => 09/479122
[patent_app_country] => US
[patent_app_date] => 2000-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 62
[patent_figures_cnt] => 101
[patent_no_of_words] => 62518
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/410/06410266.pdf
[firstpage_image] =>[orig_patent_app_number] => 09479122
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/479122 | Compositions and methods for non-targeted activation of endogenous genes | Jan 6, 2000 | Issued |
| 09/475813 | SYSTEM FOR PRODUCTION OF HELPER DEPENDENT ADVENOVIRUS VECTORS BASED ON USE OF ENDONCLEASES | Dec 29, 1999 | Abandoned |
| 09/456876 | FHAR1, a ring finger protein | Dec 7, 1999 | Abandoned |
Array
(
[id] => 4260760
[patent_doc_number] => 06258791
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-10
[patent_title] => 'Combination product for enhanced gene delivery comprising a hyaluronidase'
[patent_app_type] => 1
[patent_app_number] => 9/424741
[patent_app_country] => US
[patent_app_date] => 1999-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5825
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/258/06258791.pdf
[firstpage_image] =>[orig_patent_app_number] => 424741
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/424741 | Combination product for enhanced gene delivery comprising a hyaluronidase | Nov 28, 1999 | Issued |
Array
(
[id] => 6598230
[patent_doc_number] => 20020042384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-11
[patent_title] => 'INTEGRIN-TARGETING VECTORS HAVING TRANSFECTION ACTIVITY'
[patent_app_type] => new
[patent_app_number] => 09/424656
[patent_app_country] => US
[patent_app_date] => 1999-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11819
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20020042384.pdf
[firstpage_image] =>[orig_patent_app_number] => 09424656
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/424656 | Integrin-targeting vectors having transfection activity | Nov 28, 1999 | Issued |
| 09/440301 | METHODS OF IN VIVO GENE TRANSFER USING A SLEEPING BEAUTY TRANSPOSON SYSTEM | Nov 16, 1999 | Abandoned |
| 09/428532 | USE OF A MODIFIED BACULOVIRUS CONTAINING EXOGENOUS NUCLEIC ACID FOR THE MANUFACTURE OF A MEDICAMENT FOR DELIVERING SAID NUCLEIC ACID TO THE HEPATOCYTES | Oct 27, 1999 | Abandoned |
Array
(
[id] => 4355971
[patent_doc_number] => 06174705
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-16
[patent_title] => 'ARO1 dehydroquinate synthase of candida albicans'
[patent_app_type] => 1
[patent_app_number] => 9/425665
[patent_app_country] => US
[patent_app_date] => 1999-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17383
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/174/06174705.pdf
[firstpage_image] =>[orig_patent_app_number] => 425665
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/425665 | ARO1 dehydroquinate synthase of candida albicans | Oct 21, 1999 | Issued |
Array
(
[id] => 4292193
[patent_doc_number] => 06197546
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-06
[patent_title] => 'PcrA Helicase of Staphylococcus aureus'
[patent_app_type] => 1
[patent_app_number] => 9/398865
[patent_app_country] => US
[patent_app_date] => 1999-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13096
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/197/06197546.pdf
[firstpage_image] =>[orig_patent_app_number] => 398865
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/398865 | PcrA Helicase of Staphylococcus aureus | Sep 19, 1999 | Issued |
| 09/394226 | MATERIALS AND METHODS FOR TREATING ONCOLOGICAL DISEASE | Sep 12, 1999 | Abandoned |
Array
(
[id] => 1531765
[patent_doc_number] => 06410236
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-25
[patent_title] => 'Correcting diastolic dysfunction in heart failure'
[patent_app_type] => B1
[patent_app_number] => 09/387919
[patent_app_country] => US
[patent_app_date] => 1999-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13498
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/410/06410236.pdf
[firstpage_image] =>[orig_patent_app_number] => 09387919
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/387919 | Correcting diastolic dysfunction in heart failure | Aug 31, 1999 | Issued |
Array
(
[id] => 4386527
[patent_doc_number] => 06262247
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-17
[patent_title] => 'Polycyclic aromatic hydrocarbon induced molecules'
[patent_app_type] => 1
[patent_app_number] => 9/386493
[patent_app_country] => US
[patent_app_date] => 1999-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13689
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/262/06262247.pdf
[firstpage_image] =>[orig_patent_app_number] => 386493
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/386493 | Polycyclic aromatic hydrocarbon induced molecules | Aug 29, 1999 | Issued |
Array
(
[id] => 4245495
[patent_doc_number] => 06221631
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-24
[patent_title] => 'tktA'
[patent_app_type] => 1
[patent_app_number] => 9/382106
[patent_app_country] => US
[patent_app_date] => 1999-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13009
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/221/06221631.pdf
[firstpage_image] =>[orig_patent_app_number] => 382106
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/382106 | tktA | Aug 23, 1999 | Issued |
Array
(
[id] => 4416113
[patent_doc_number] => 06194174
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-27
[patent_title] => 'Histidine kinase, 636 HK, of staphylococcus aureus'
[patent_app_type] => 1
[patent_app_number] => 9/310275
[patent_app_country] => US
[patent_app_date] => 1999-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12734
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/194/06194174.pdf
[firstpage_image] =>[orig_patent_app_number] => 310275
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/310275 | Histidine kinase, 636 HK, of staphylococcus aureus | May 11, 1999 | Issued |
| 09/304755 | METHODS AND COMPOUNDS FOR PREVENTION OF GRAFT REJECTION | May 3, 1999 | Abandoned |
| 09/276872 | YDJB | Mar 25, 1999 | Abandoned |
| 09/250929 | SYSTEM FOR PRODUCTION OF HELPER DEPENDENT ADENOVIRUS VECTORS BASED ON USE OF ENDONUCLEASES | Feb 17, 1999 | Abandoned |
Array
(
[id] => 4352233
[patent_doc_number] => 06291423
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-18
[patent_title] => 'Lipid complexes for transferring at least a therapeutically active substance, in particular a polynucleotide into a target cell and use in gene therapy'
[patent_app_type] => 1
[patent_app_number] => 9/242258
[patent_app_country] => US
[patent_app_date] => 1999-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 11112
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/291/06291423.pdf
[firstpage_image] =>[orig_patent_app_number] => 242258
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/242258 | Lipid complexes for transferring at least a therapeutically active substance, in particular a polynucleotide into a target cell and use in gene therapy | Feb 11, 1999 | Issued |
